1
0
0
(1 - 14 von 24
)
Katja ROESCH | University of Leipzig, Leipzig | Research profile
www.researchgate.net
Katja Roesch · Dirk Hasenclever · Markus Scholz. Dose and time intensifications of chemotherapy improved the outcome of lymphoma therapy. › Katj...
and immunotherapy of high-grade non-Hodgkin lymphoma
www.tandfonline.com
von K Rösch · · Zitiert von: 6 — CONTACT Dirk Hasenclever -leipzig.de. Institute for Medical Informatics, Statistics & Epidemiology (IMISE), University ... › doi › pdf
Hodgkin Lymphoma - Google Books
books.google.de
The definitive text on Hodgkin lymphoma is now in its thoroughly revised, updated Second Edition. More than 100 recognized authorities from all parts of the...
Malignant Lymphomas - Michael L. Grossbard, American Cancer Society -...
books.google.de
Part of the acclaimed ACS Atlas of Clinical Oncology series, this book is designed to summarize current knowledge on the pathology, epidemio logy, molecular...
Hodgkin Lymphoma - Seite Google Books-Ergebnisseitebooks.google.com › books
books.google.de
LENA SPECHT AND DIRK HASENCLEVER and predicting outcome for individual patients However , it is important to realize that we cannot predict exactly ...
Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by...
www.ikmb.uni-kiel.de
ikmb - Institut für Klinische Molekularbiologie Sabine Adam-Klages, Gordana Apic, Alexander Claviez, Dirk Hasenclever, Volker Hovestadt, Nadine Hornig ...
Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by...
www.nature.com
Reiner Siebert and colleagues report whole-genome, whole-exome and transcriptome sequencing of Burkitt lymphomas. They identify recurrent mutations in several...
CHOEP for aggressive NHL in younger patients - Lymphoma.com -...
forums.lymphoma.com
CHOEP for aggressive NHL in younger patients Non-Hodgkin's Peer Support and News
Dirk Hasenclever
www.infona.pl
Dirk Hasenclever. Details · Publications ... Lena Specht, Dirk Hasenclever · Hodgkin Lymphoma > Diagnosis and Treatment. The concept that ...
Subproject 1: Modelling the Treatment of Diffuse Large B-Cell...
www.haematosys.de
Subproject 1: Modelling the Treatment of Diffuse Large B-Cell Lymphoma
Hodgkin Lymphoma leads to increased hematotoxicity without ...
europepmc.org
von K Hohloch · · Zitiert von: 6 — Karin Hohloch, Carsten Zwick, Marita Ziepert, Dirk Hasenclever, Ulrich Kaiser, Andreas Engert, Heinz-Gert Höffkes, Frank Kroschinsky, Rolf Mesters, ... › pmc
Interim PET in Diffuse Large B-Cell Lymphoma
jnm.snmjournals.org
Lars Kurch, Andreas Hüttmann, Thomas W. Georgi, Jan Rekowski, Osama Sabri, Christine Schmitz, Regine Kluge, Ulrich Dührsen and Dirk Hasenclever. › content
Intra-tumor heterogeneity, turnover rate and karyotype space ...
www.biorxiv.org
von GJ Kimmel · — Katja Roesch, Dirk Hasenclever, and Markus Scholz. Modelling lymphoma therapy and outcome. Bulletin of mathematical biology, 76(2):401–430, ... › content
Web Supplement to A Biologic Definition of Burkitt's Lymphoma from ...
compdiag.molgen.mpg.de
Institute for Medical Informatics, Statistics and Epidemiology, Universität Leipzig, Germany (Hilmar Berger, Dirk Hasenclever, Markus Loeffler);
Alle Infos zum Namen "Dirk Hasenclever"
sortiert nach Relevanz / Datum